Therapeutic behavior of primary care physicians in patients with atrial fibrillation taking vitamin K antagonists not adequately controlled

In the majority of patients with atrial fibrillation (AF), long-term oral anticoagulation is necessary to reduce the risk of stroke. Although effective, vitamin K antagonists (VKAs) exhibit many limitations [1,2]. Despite that, they are still widely used in clinical practice [3].